MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue

Area of Science:

• Biomedical Imaging
• Pharmacology
• Cardiology

Background:

• Manganese dipyridoxyl diphosphate (MnDPDP) was previously an MRI contrast agent.
• It has shown potential for enhanced imaging in various organs.
• MnDPDP also possesses cytoprotective and antioxidant properties.

Purpose of the Study:

• To re-evaluate MnDPDP for clinical use as a diagnostic drug with cytoprotective properties.
• To explore its potential in diagnosing heart disease and treating oxidative stress.
• To update current knowledge on MnDPDP's clinical applications.

Main Methods:

• Review of existing literature on MnDPDP's mechanism of action and clinical applications.
• Analysis of MnDPDP's role in manganese-ion-enhanced MRI (MEMRI).
• Evaluation of its transmetallation process and intracellular effects on T1 relaxation times.

Main Results:

• MnDPDP releases paramagnetic Mn2+ ions for cellular uptake, enhancing MRI contrast.
• Intracellular Mn2+ adducts lower myocardial T1, enabling quantitative viability assessment.
• MnDPDP and its metabolite MnPLED act as antioxidants, mitigating oxidative stress.

Conclusions:

• MnDPDP holds significant potential as a diagnostic agent for conditions like heart disease.
• Its cytoprotective and antioxidant functions offer therapeutic benefits, particularly in managing oxidative stress.
• Further exploration of its theranostic applications combining therapy and delayed imaging is warranted.